Issue 40 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

21

No.

40

October 20, 1995Oct 20, 1995

Free

DOWNLOAD THE PDF

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

Petition Filed To Revoke NlH License To Use Radioactive Materials

Extramural Advisory Board Members Listed

Komen Foundation Awards New Grants

Recent Issues

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026

Volume 52 | Issue 19 - May 15, 2026